Topchoice Medical Co., Inc. (SHA:600763)
China flag China · Delayed Price · Currency is CNY
36.79
-0.09 (-0.24%)
Aug 3, 2026, 3:00 PM CST

Topchoice Medical Co. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
504.99501.95501500.44548.27702.81
Depreciation & Amortization
190.93190.93203.41189.35173.31153.8
Other Amortization
72.572.564.4555.2546.135
Loss (Gain) From Sale of Assets
0.270.27-0.14-0.050.02
Asset Writedown & Restructuring Costs
0.360.360.860.420.510.21
Loss (Gain) From Sale of Investments
-47.33-47.33-47.84-60.19-38.3-56.13
Provision & Write-off of Bad Debts
11.3511.353.171.751.671.29
Other Operating Activities
133.16122.82114.15131.85117.71109.25
Change in Accounts Receivable
-42.73-42.73-28.94-37.77-45.07-46.88
Change in Inventory
10.2210.22-3.74-1.9-2.55-2.68
Change in Accounts Payable
-3.78-3.78-37.371.22-122.1236.97
Change in Other Net Operating Assets
-1.64-1.64-1.64-1.64-1.64-1.64
Operating Cash Flow
824.1810.72762.99841.02670.05939.41
Operating Cash Flow Growth
5.53%6.25%-9.28%25.52%-28.67%32.59%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-236.15-246.2-332.11-508.9-421.53-367.32
Sale of Property, Plant & Equipment
2.152.152.020.010.620.02
Cash Acquisitions
-15-15-27.73---
Divestitures
----0.03-131.95
Investment in Securities
8.3811.11-7.04-504.25-60.45-234.42
Other Investing Activities
-55.01-31.31-96.1-14.47-15.99-14
Investing Cash Flow
-295.62-279.24-324.97-887.63-497.35-483.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-5080280--
Long-Term Debt Repaid
--224.81-252.43-193.57-251.18-241.76
Net Debt Issued (Repaid)
-13.81-174.81-172.4386.43-251.18-241.76
Repurchase of Common Stock
---30.1-1-99.99-
Common Dividends Paid
-209.11-208.89-149.89-11.24-6.69-12.87
Other Financing Activities
-110.31-71.32-59.85-63.04-28.33-31.3
Financing Cash Flow
-333.23-455.02-412.2811.15-386.19-285.93

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
195.2576.4625.74-35.46-213.5169.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
587.96564.52430.88332.13248.52572.09
Free Cash Flow Growth
14.15%31.02%29.73%33.64%-56.56%6.33%
Free Cash Flow Margin
20.11%19.38%14.99%11.67%9.14%20.57%
Free Cash Flow Per Share
1.311.260.960.740.551.27
Levered Free Cash Flow
365.91330.95375.96331.44-199.6365.3
Unlevered Free Cash Flow
387.47353.36404.36365.82-168.32383.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
154.5153.52162.07142.52227.01105.67
Change in Working Capital
-42.12-42.12-76.0622.15-179.26-6.83